<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE ep-patent-document PUBLIC "-//EPO//EP PATENT DOCUMENT 1.4//EN" "ep-patent-document-v1-4.dtd">
<ep-patent-document id="EP05817611B8W1" file="EP05817611W1B8.xml" lang="en" country="EP" doc-number="1969003" kind="B8" correction-code="W1" date-publ="20101110" status="c" dtd-version="ep-patent-document-v1-4">
<SDOBI lang="en"><B000><eptags><B001EP>ATBECHDEDKESFRGBGRITLILUNLSEMCPTIESILTLVFIRO..CY..TRBGCZEEHUPLSK....IS..............................</B001EP><B003EP>*</B003EP><B005EP>J</B005EP><B007EP>DIM360 Ver 2.15 (14 Jul 2008) -  2999001/0</B007EP></eptags></B000><B100><B110>1969003</B110><B120><B121>CORRECTED EUROPEAN PATENT SPECIFICATION</B121></B120><B130>B8</B130><B132EP>B1</B132EP><B140><date>20101110</date></B140><B150><B151>W1</B151><B153>73</B153><B155><B1551>de</B1551><B1552>Bibliographie</B1552><B1551>en</B1551><B1552>Bibliography</B1552><B1551>fr</B1551><B1552>Bibliographie</B1552></B155></B150><B190>EP</B190></B100><B200><B210>05817611.6</B210><B220><date>20051214</date></B220><B240><B241><date>20080619</date></B241><B242><date>20090619</date></B242></B240><B250>en</B250><B251EP>en</B251EP><B260>en</B260></B200><B400><B405><date>20101110</date><bnum>201045</bnum></B405><B430><date>20080917</date><bnum>200838</bnum></B430><B450><date>20100908</date><bnum>201036</bnum></B450><B452EP><date>20100512</date></B452EP><B480><date>20101110</date><bnum>201045</bnum></B480></B400><B500><B510EP><classification-ipcr sequence="1"><text>C07K  14/475       20060101AFI20070813BHEP        </text></classification-ipcr><classification-ipcr sequence="2"><text>A61K  38/18        20060101ALI20070813BHEP        </text></classification-ipcr><classification-ipcr sequence="3"><text>C12N  15/12        20060101ALI20070813BHEP        </text></classification-ipcr><classification-ipcr sequence="4"><text>C07K  16/22        20060101ALI20070813BHEP        </text></classification-ipcr></B510EP><B540><B541>de</B541><B542>Verwendungen eines neurotrophischen Faktors</B542><B541>en</B541><B542>Uses of a NEUROTROPHIC FACTOR PROTEIN</B542><B541>fr</B541><B542>Utilisations d'un FACTEUR NEUROTROPHIQUE</B542></B540><B560><B561><text>WO-A-02/074956</text></B561><B561><text>WO-A2-01/19851</text></B561><B561><text>WO-A2-02/074956</text></B561><B561><text>WO-A2-02/079246</text></B561><B561><text>US-A1- 2004 053 250</text></B561><B561><text>US-A1- 2006 084 619</text></B561><B562><text>DATABASE UniProt [Online] 13 September 2005 (2005-09-13), "RecName: Full=ARMET-like protein 1; AltName: Full=Conserved dopamine neurotrophic factor; Short=CDNF; Flags: Precursor;" XP002507602 retrieved from EBI accession no. UNIPROT:Q49AH0 Database accession no. Q49AH0</text></B562><B562><text>PETROVA PENKA S ET AL: "MANF: A new mesencephalic, astrocyte-derived neurotrophic factor with selectivity for dopaminergic neurons." JOURNAL OF MOLECULAR NEUROSCIENCE, vol. 20, no. 2, April 2003 (2003-04), pages 173-187, XP009109890 ISSN: 0895-8696</text></B562><B562><text>LINDHOLM PÄIVI ET AL: "Novel neurotrophic factor CDNF protects and rescues midbrain dopamine neurons in vivo." NATURE 5 JUL 2007, vol. 448, no. 7149, 5 July 2007 (2007-07-05), pages 73-77, XP002507601 ISSN: 1476-4687</text></B562><B562><text>DATABASE GENESEQ [Online] 11 March 2004 XP003015716 Database accession no. (ADG79480)</text></B562><B562><text>DATABASE GENESEQ [Online] 11 March 2004 XP003015717 Database accession no. (ADG79397)</text></B562><B562><text>DATABASE REGISTRY [Online] 27 September 2002 XP003015718 Retrieved from STN Database accession no. (455961-28-1)</text></B562><B562><text>DATABASE REGISTRY [Online] 27 September 2002 XP003015719 Retrieved from STN Database accession no. (455962-11-5)</text></B562><B562><text>DATABASE GENESEQ [Online] 30 December 2004 XP003015720 Database accession no. (ADS98795)</text></B562><B562><text>DATABASE REGISTRY [Online] 20 October 2004 XP003015721 Retrieved from STN Database accession no. (766439-79-6)</text></B562><B565EP><date>20090219</date></B565EP></B560></B500><B700><B720><B721><snm>SAARMA, Mart</snm><adr><str>Kulosaaren Puistotie 38 A 4</str><city>FI-00570 Helsinki</city><ctry>FI</ctry></adr></B721><B721><snm>LAUREN, Juha</snm><adr><str>173 Park St., apt. 1</str><city>New Haven, CT 06510</city><ctry>US</ctry></adr></B721><B721><snm>LINDHOLM, Päivi</snm><adr><str>Hiekkaharjuntie 15 B 17</str><city>FI-01300 Vantaa</city><ctry>FI</ctry></adr></B721><B721><snm>TIMMUSK, Tonis</snm><adr><str>Mesila 7A</str><city>EE-10919 Tallinn</city><ctry>EE</ctry></adr></B721><B721><snm>TUOMINEN, Raimo</snm><adr><str>Vanha Hämeenkyläntie 47 A</str><city>FI-01650 Vantaa</city><ctry>FI</ctry></adr></B721></B720><B730><B731><snm>Hermo Pharma Ltd.</snm><iid>101201681</iid><irf>46486</irf><adr><str>Viikinkaari 4</str><city>00790 Helsinki</city><ctry>FI</ctry></adr></B731></B730><B740><B741><snm>Matilainen, Mirja Helena</snm><sfx>et al</sfx><iid>100040057</iid><adr><str>Oy Jalo Ant-Wuorinen AB, 
Iso Roobertinkatu 4-6 A</str><city>00120 Helsinki</city><ctry>FI</ctry></adr></B741></B740></B700><B800><B840><ctry>AT</ctry><ctry>BE</ctry><ctry>BG</ctry><ctry>CH</ctry><ctry>CY</ctry><ctry>CZ</ctry><ctry>DE</ctry><ctry>DK</ctry><ctry>EE</ctry><ctry>ES</ctry><ctry>FI</ctry><ctry>FR</ctry><ctry>GB</ctry><ctry>GR</ctry><ctry>HU</ctry><ctry>IE</ctry><ctry>IS</ctry><ctry>IT</ctry><ctry>LI</ctry><ctry>LT</ctry><ctry>LU</ctry><ctry>LV</ctry><ctry>MC</ctry><ctry>NL</ctry><ctry>PL</ctry><ctry>PT</ctry><ctry>RO</ctry><ctry>SE</ctry><ctry>SI</ctry><ctry>SK</ctry><ctry>TR</ctry></B840><B860><B861><dnum><anum>FI2005050461</anum></dnum><date>20051214</date></B861><B862>en</B862></B860><B870><B871><dnum><pnum>WO2007068784</pnum></dnum><date>20070621</date><bnum>200725</bnum></B871></B870><B880><date>20080917</date><bnum>200838</bnum></B880></B800></SDOBI>
</ep-patent-document>
